Companies: 10,795·Total market cap: $144.5T
Precipio, Inc.

Precipio, Inc.

PRPONASDAQHealthcare● Active
$23.00
$-0.49(-2.09%)
Market Cap$41109510
P/E Ratio
52W High$33.63
52W Low$10.5

Precipio, Inc. (PRPO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

prpo · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Precipio, Inc. (PRPO) measures how much investors pay for each dollar of the company's trailing earnings. PRPO's current PE ratio of N/A is calculated by dividing its stock price of $23.00 by its TTM earnings per share of -$0.52.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
0.84x
FY2026 est. EPS $27.40
Based on 1 analyst
EPS (TTM)
-$0.52
TTM · diluted EPS
PEG Ratio
0.86
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Precipio, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Precipio, Inc.
Precipio, Inc.You
PRPO
$41MN/A-$0.52
Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc
APUS
$2MN/A-$0.55
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
INTS
$7MN/A-$0.86
Iterum Therapeutics plc
Iterum Therapeutics plc
ITRM
$2MN/A-$1.26
Longduoduo Company Limited
Longduoduo Company Limited
LDDD
$28M325.23x$0.02
Milestone Scientific Inc.
Milestone Scientific Inc.
MLSS
$34MN/A-$0.07
Modular Medical, Inc.
Modular Medical, Inc.
MODD
$10MN/A-$15.26

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.23
2024-12-31
FY2024
$-2.93
2023-12-31
FY2023
$-4.51
2022-12-31
FY2022
$-10.73
2021-12-31
FY2021
$-8.10
2020-12-31
FY2020
$-12.90
2019-12-31
FY2019
$-46.51
2018-12-31
FY2018
$-217.81
2017-12-31
FY2017
$-1338.20
2016-12-31
FY2016
$-158453.20

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Precipio, Inc. (PRPO) measures how much investors pay for each dollar of the company's trailing earnings. PRPO's current PE ratio of N/A is calculated by dividing its stock price of $23.00 by its TTM earnings per share of -$0.52.

PE Ratio = Stock Price ÷ EPS (TTM)
= $23.00 ÷ -$0.52 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

PRPO pe ratio · 6 questions

PRPO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $23.00 and TTM EPS of -$0.52. Data sourced from Financial Modeling Prep via PRPO's SEC 10-K and 10-Q filings.

PRPO PE ratioWhat is PRPO PE ratioCurrent PE ratio of PRPOPRPO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Precipio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09